Search Results

You are looking at 1 - 10 of 25 items for :

  • "sarcopenia" x
  • Refine by Access: All x
Clear All
Full access

Effect of Preexisting Sarcopenia on Acute and Late Postoperative Pneumonia Among Patients With Oral Cavity Squamous Cell Carcinoma

Yi-Nong Chen, Ching-Wen Chiang, Yu-Hsiang Tsai, Wan-Ming Chen, Mingchih Chen, Ben-Chang Shia, Chun-Chi Huang, and Szu-Yuan Wu

prevalence of POP among patients with OCSCC who received curative surgery or has identified correctable preexisting risk factors for POP in patients with OCSCC who received curative surgery. Sarcopenia is a condition that is characterized by loss of muscle

Full access

Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112

Tarah J. Ballinger, Helga S. Marques, Gloria Xue, Richard Hoffman, Constantine Gatsonis, Fengmin Zhao, Kathy D. Miller, Joseph Sparano, and Roisin M. Connolly

receiving chemotherapy for MBC found sarcopenia (defined as LMM) was associated with increased therapy-related toxicity, but had an inconsistent impact on progression and survival outcomes (Lee et al, 15 N=53; Shachar et al, 8 N=40; and Prado et al, 7 N

Full access

Skeletal Muscle Quality Beyond Average Muscle Attenuation: A Proposal of Skeletal Muscle Phenotypes to Predict Short-Term Survival in Patients With Endometrial Cancer

Camila Santos Rodrigues and Gabriela Villaça Chaves

Sarcopenia was first described as a geriatric syndrome with multifactorial etiology, consisting of low muscle mass combined with low muscle strength or impaired physical performance. 1 A decrease in muscle mass and strength have also been

Full access

Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy

Kyuwan Lee, Aleksi Iukuridze, Tianhui He, Alysia Bosworth, Lanie Lindenfeld, Jennifer Berano Teh, Meagan Echevarria, Sophia Albanese, Liezl Atencio, Rusha Bhandari, F. Lennie Wong, Andrew S. Artz, Tanya Siddiqi, Liana Nikolaenko, Jasmine Zain, Matthew Mei, Geoffrey Shouse, Leslie L. Popplewell, Alex F. Herrera, L. Elizabeth Budde, Stephen J. Forman, and Saro H. Armenian

link between sarcopenia and immune senescence . EBioMedicine 2019 ; 49 : 381 – 388 . 31662290 6. van de Schans SA , van Steenbergen LN , Coebergh JW , Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma

Full access

Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer

Emily van Seventer, J. Peter Marquardt, Amelie S. Troschel, Till D. Best, Nora Horick, Chinenye Azoba, Richard Newcomb, Eric J. Roeland, Michael Rosenthal, Christopher P. Bridge, Joseph A. Greer, Areej El-Jawahri, Jennifer Temel, Florian J. Fintelmann, and Ryan D. Nipp

% of all cancer deaths. 3 – 5 Notably, patients who meet criteria for sarcopenia (ie, low muscle mass) experience poor treatment tolerability and decreased survival. 6 – 10 Although prior studies have described the adverse effects of low muscle mass

Full access

Letter to the Editor: Differentiating Between Intentional Versus Unintentional Weight Loss

Leah Puklin, Melinda L. Irwin, Tara Sanft, and Leah M. Ferrucci

metabolic biomarkers. 3 , 4 Comparatively, weight loss potentially from underlying disease can result in sarcopenia (loss of muscle mass), which is associated with increased risk of mortality among patients with early breast cancer. 5 It is also important

Full access

Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies

Grant R. Williams, Marc S. Weinberg, and Shlomit S. Shachar

MS Shachar SS Muss HB . Beyond sarcopenia: characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population . Breast J 2017 ; 24 : 278 – 284 . 3. Shachar SS Deal AM Weinberg M . Body

Full access

Cachexia and Dietetic Interventions in Patients With Esophagogastric Cancer: A Multicenter Cohort Study

Willemieke P.M. Dijksterhuis, Anouk E.J. Latenstein, Jessy Joy van Kleef, Rob H.A. Verhoeven, Jeanne H.M. de Vries, Marije Slingerland, Elles Steenhagen, Joos Heisterkamp, Liesbeth M. Timmermans, Marian A.E. de van der Schueren, Martijn G.H. van Oijen, Sandra Beijer, and Hanneke W.M. van Laarhoven

questionnaires during follow-up. Cachexia was defined as >5% body-weight loss or >2% in individuals with a BMI of <20 kg/m 2 according to international consensus criteria. 13 The criterion for cachexia that included the presence of sarcopenia was not used

Full access

Anemia and Functional Disability in Older Adults With Cancer

Cynthia Owusu, Harvey Jay Cohen, Tao Feng, William Tew, Supriya G. Mohile, Heidi D. Klepin, Cary P. Gross, Ajeet Gajra, Stuart M. Lichtman, Arti Hurria, and on behalf of the Cancer and Aging Research Group (CARG)

, 28 Evidence from cross-sectional studies has shown an inverse association between biomarkers of inflammation and sarcopenia (loss of skeletal muscle mass and strength), slower walking speed, and functional disability. 29 – 32 Prospective studies

Full access

The Future of Geriatric Oncology Research: Moving Toward Interventions and Objective Biomarkers of Aging

Efrat Dotan

inflammatory markers (eg, IL-6, C-reactive protein, tumor necrosis factor-α, D-dimer), markers of cellular senescence (eg, P16 INK 4A), and sarcopenia. These biomarkers demonstrated correlation with frailty, functional decline, and survival. 9 However, a clear